Hybrid Purifer Enhances Efficiency - - BioPharm International


Hybrid Purifer Enhances Efficiency

BioPharm International
Volume 27, Issue 8, pp. 44

3M’s Emphaze AEX Hybrid Purifier combines polymers, fine fiber nonwovens, and membranes to create an all-synthetic clarifying product line containing anion exchange nonwoven media and a fine particle, bioburden reduction membrane. The defined pore size of the qualifying membrane provides removal of insoluble particles below 0.1 μm in size, resulting in turbidity reduction.

In addition, the high chromatographic capacity of the Q-functional nonwoven provides reduction of negatively charged, soluble impurities including DNA and HCP. This combination of attributes allows the hybrid purifier to provide product purity before and after the Protein A column, enabling an easy post-Protein A monoclonal antibody (mAb) purification process.

According to the company, this purifier can improve the production of mAb drugs for various cancers, as well as autoimmune diseases such as rheumatoid arthritis and psoriasis.


blog comments powered by Disqus



J&J Speeds Ebola Vaccine Development and Expands Production
October 24, 2014
GSK Accelerates Ebola Vaccine Development
October 24, 2014
Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
October 24, 2014
Manufacturing Challenges of mAb Production: CHO or Plant Cells?
October 24, 2014
Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Author Guidelines
Source: BioPharm International,
Click here